Etiology of balkan endemic nephropathy and associated urothelial cancer

American Journal of Nephrology

Volumn 26, Issue 1, 2006, Pages 1-11

  Stefanovic, Vladisav ^a   Toncheva, Draga ^b   Atanasova, Srebrena ^c   Polenakovic, Momir ^d  

^a Faculty of Medicine   (Serbia)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

Author keywords

Aristolochic acid; Balkan endemic nephropathy, etiology; Balkan endemic nephropathy, genetic predisposition; Ochratoxin A; Polycyclic aromatic hydrocarbons; Urothelial cancer; Xenobiotic metabolizing genes

Indexed keywords

ALCOHOL; ARISTOLOCHIC ACID; COAL; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DRINKING WATER; EPIDERMAL GROWTH FACTOR; GLUTATHIONE TRANSFERASE; LIGNITE; MULTIDRUG RESISTANCE PROTEIN 1; MYCOTOXIN; OCHRATOXIN; ORGANIC COMPOUND; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; PORPHOBILINOGEN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

AGING; ALCOHOL CONSUMPTION; ANEMIA; ARISTOLOCHIA; BLADDER TUMOR; CHROMOSOME ABERRATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC STABILITY; GENETIC SUSCEPTIBILITY; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HEMODIALYSIS; HEREDITY; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY PELVIS TUMOR; KIDNEY TRANSPLANTATION; LEACHING; MOUSE STRAIN; NOCTURIA; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PLIOCENE; POLLUTION; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; PROTEOMICS; RABBIT; RAT STRAIN; RENAL REPLACEMENT THERAPY; REVIEW; RODENT; SMOKING; URIC ACID URINE LEVEL; URINALYSIS; UROGENITAL TRACT CANCER; VIRUS PARTICLE;

EID: 33645690974     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090705     Document Type: Review

References (71)

1. Polenakovic M, Stefanovic V: Balkan Nephropathy; in Cameron JS, Davison AM, Grunfeld JP, Kerr D, Ritz E (eds): Oxford Textbook of Clinical Nephrology, ed 1. Oxford, Oxford University Press, 1992, pp 857-866.
2. Stefanovic V: Balkan endemic nephropathy: a need for novel aetiological approaches. Q J Med 1998;91:457-463.
3. Stefanovic V, Cosyns JP: Balkan Nephropathy; in Davison AM, Cameron JS, Grunfeld JP, Ponticelli C, Van Ypersele C, Ritz E, Winearls CG (eds): Oxford Textbook of Clinical Nephrology, ed 3. Oxford, Oxford University Press, 2004, pp 1095-1102.
4. Cukuranovic R, Petrovic B, Cukuranovic Z, Stefanovic V: Balkan endemic nephropathy: a decreasing incidence of the disease. Pathol Biol 2000;48:558-561.
5. Dimitrov PS, Simeonov VA, Ganev VS, Karmaus WJ: Is the incidence of Balkan endemic nephropathy decreasing? Pathol Biol 2002;50:38-41.
6. Djukanovic L, Radovic M, Bakovic J, et al: Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia. Int J Artif Organs 2002;25:852-859.
7. Petkovic S, Mutavdzic M, Petronic V, Markovic V: Les tumeurs du bassinet et de l'uretère. Recherches cliniques et étiologiques. J Urol Néphrol 1971;77:429-439.
8. Chernozemsky IN, Stoyanov IS, Petkova-Bocharova TK, et al: Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district, Bulgaria. Int J Cancer 1977;19:1-11.
9. Cukuranovic R, Ignjatovic M, Stefanovic V: Urinary tract tumors and Balkan nephropathy in the South Morava River basin. Kidney Int 1991;40(suppl 34):S80-S84.
10. Markovic N, Ignjatovic I, Cukuranovic R, et al: Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery-based study from 1969 to 1998. Pathol Biol 2005;53:26-29.
11. Toncheva D, Dimitrov T, Stojanova S: Etiology of Balkan endemic nephropathy: a multifactorial disease? Eur J Epidemiol 1998;14:389-394.
12. Pavlovic NM, Vargheze Z, Persaud JW, et al: Partial lecithin:cholesterol acyltransferase deficiency in Balkan endemic nephropathy. Kidney Int 1991;40(suppl 34):S102-S105.
13. Djordjevic VB, Strahinjic S, Koracevic D, et al: δ-Aminolevulinate dehydratase measurements in Balkan endemic nephropathy. Kidney Int 1991;40(suppl 34):S93-S96.
14. Nikolov I, Chernozemsky I, Idle J: Genetic predisposition to Balkan endemic nephropathy: ability hydroxylate debrisoquine as a host factor; in Castegnaro M, Plestina R, Dirheimer G, Chernozemsky I, Bartasch H (eds): Mycotoxins, endemic nephropathy and urinary tract tumors. Lyon, IARC, 1991, pp 289-296.
15. 450 among patients with Balkan endemic nephropathy. Clin Biochem 2005;38:223-228.
16. Toncheva D, von Ahsen D, Atanasova S, et al: Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol 2004;17:384-389.
17. Andonova R, Sarueva A, Horvath V, et al: Balkan endemic nephropathy and genetic variants of glutathione S-transferases. J Nephrol 2004;17:390-398.
18. Atanasova S, von Ahsen N, Dimitrov T, et al: First study of NAT1 and NAT2 polymorphisms in Bulgarian patients with Balkan endemic nephropathy and healthy controls. Biotechnol Biotechnol Equip 2004;18:95-103.
19. Zepnik H, Pahler A, Schauer U, Dekant W: Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci 2001;59:59-67.
20. Perri D, Ito S, Rowsell V, Shear NH: The kidney - the body's playground for drugs: an overview of renal drug handling with selected clinical correlates. Can J Clin Pharmacol 2003;10:17-23.
21. Kim RB, Leake BF, Choo EF, et al: Identification of functionally variant MDR1 alleles among European-Americans and African-Americans. Clin Pharmacol Ther 2001;70:189-199.
22. Atanasova S, von Ahsen N, Dimitrov T, et al: MDR1 haplotypes modify BEN disease risk: a study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls. Nephron Exp Nephrol 2004;96:e7-e13.
23. Klahr S: Progression of chronic renal disease. Heart Dis 2001;3:205-209.
24. Pelletier R, Pravica V, Perrey C, et al: Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000;70:674-680.
25. 1 gene polymorphism in heart transplant recipients - effect on renal function. Ann Transplant 2001;6:39-43.
26. 1 polymorphism Thr263I1e in patients with Balkan endemic nephrology and in healthy Bulgarian population. Balkan J Med Genet 2002;5:37-41.
27. 1 gene in relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-887.
28. Toncheva DI, Gerov TD, Tzoneva MT, Bouchakliev ZP: Spontaneous and induced chromosome aberrations in Balkan endemic nephropathy. Kidney Int 1991;40(suppl 34):S97-S101.
29. Toncheva D, Dimitrov T, Tzoneva M: Cytogenetic studies in Balkan endemic nephropathy. Nephron 1988;48:18-21.
30. Toncheva D, Dimitrov T: Genetic predisposition to Balkan endemic nephropathy. Nephron 1996;72:564-569.
31. Toncheva D, Atanassova S, Gergov T, et al: Genetic changes in uroepithelial tumors of patients with Balkan endemic nephropathy. J Nephrol 2002;15:387-393.
32. Danilovic V, Djurisic M, Mokranjac M, et al: Néphrites chroniques provoquées par l'intoxication au plomb par voie digestive (farine). Presse Méd 1957;65:2039-2040.
33. Maksimovic ZJ: Selenium deficiency and Balkan endemic nephropathy. Kidney Int 1991;40(suppl 34):S12-S14.
34. Cukuranovic R, Nikolic J, Stefanovic V: Erythrocyte glutathione peroxidase activity in patients with Balkan endemic nephropathy and in their healthy family members. Arch Biol Sci 1992;44:23-30.
35. Stefanovic V, Cukuranovic R, Mitic-Zlatkovic M, Hall PW: Increased urinary albumin excretion in children from families with Balkan nephropathy. Pediatr Nephrol 2002;17:913-916.
36. Stefanovic V, Mitic-Zlatkovic M, Cukuranovic R, Vlahovic P: Increased urinary protein excretion in children from families with Balkan endemic nephropathy. Nephron Clin Pract 2003;95:C116-C120.
37. Ivić M: The problem of etiology of endemic nephropathy. Acta Fac Med Naiss 1970;1:29-37.
38. Hranjec T, Kovac A, Kos J, et al: Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J 2005;46:116-125.
39. Vanherweghem JL, Depierreux M, Tielmans C, et al: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-391.
40. Cosyns JP, Jadoul M, Squifflet JP, et al: Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994;45:1680-1688.
41. Cosyns JP, Jadoul M, Squifflet JP, et al: Urothelial lesions in Chinese herb nephropathy. Am J Kidney Dis 1999;33:1011-1017.
42. Nortier JL, Muniz MC, Schmeiser HH, et al: Urothelial carcinoma associated with the use of a Chinese herbs (Aristolochia species). N Engl J Med 2000;342:1686-1692.
43. Stefanovic V: Analgesic nephropathy, Balkan endemic nephropathy and Chinese herbs nephropathy: separate tubulointerstitial kidney diseases associated with urothelial malignancy. Facta Universitatis 2002;9:1-6.
44. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M: Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 1996;27:209-215.
45. Arlt VM, Stiborova M, Schmeiser HH: Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-277.
46. Schmeiser HH, Bieler CA, Wiessler M, et al: Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996;56:2025-2028.
47. Arlt VM, Pfohl-Leszkowicz A, Cosyns JP, Schmeiser HH: Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 2001;494:143-150.
48. Arlt VM, Wiessler M, Schmeiser HH: Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene. Carcinogenesis 2000;21:235-242.
49. Lord GM, Hollstein M, Arlt VM, et al: DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis 2004;43:e11-e17.
50. Cosyns JP, Dehoux JP, Guiot Y, et al: Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001;59:2164-2173.
51. Debelle FD, Nortier JL, de Prez EG, et al: Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 2002;13:431-436.
52. Arlt VM, Ferluga D, Stiborova M, et al: Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 2002;101:500-502.
53. Krogh P, Axelsen NH, Elling F, et al: Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin-A-contaminated food. Acta Pathol Microbiol Scand [A] 1974;246(suppl):1-24.
54. Krogh P, Hald B, Pleština R, Čeović S: Balkan (endemic) nephropathy and foodborne ochratoxin A: preliminary results of a survey of food-stuffs. Acta Pathol Microbiol Scand, B Microbiol 1977;85:238-240.
55. Pfohl-Leszkowicz A, Grosse Y, Kane A, et al: Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 1993;289:265-273.
56. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, et al: Ochratoxin A related DNA adducts in urinary tract tumours of Bulgarian subjects. IARC Sci Publ 1993;124:141-148.
57. Mantle PG: Experimental mycotoxic nephropathies and Balkan endemic nephropathy. Facta Universitatis 2002;9:64-65.
58. Savin M, Bumbasirevic V, Djukanovic L, Petronic V: The significance of apoptosis for early diagnosis of Balkan nephropathy. Nephrol Dial Transplant 2001;16(suppl 6):S30-S32.
59. Feder GL, Radovanović Z, Finkelman RB: Relationship between weathered coal deposits and the aetiology of Balkan endemic nephropathy. Kidney Int 1991;40(suppl 34):S9-S11.
60. Goldberg MC, Feder GL, Radovanovic Z: Correlation of Balkan endemic nephropathy with fluorescent organic compounds in shallow ground water. Appl Hydrogeol 1994;2:15-23.
61. Voice TC, McElmurry SP, Long DT, et al: Evaluation of coal leachate contamination of water supplies as a hypothesis for the occurrence of Balkan endemic nephropathy in Bulgaria. Facta Universitatis 2002;9:128-129.
62. Niagolova N, McEllmurry SP, Voice TC, et al: Nitrogen species in drinking water indicate potential exposure pathway for Balkan endemic nephropathy. Envir Pollut 2005;134:229-237.
63. Apostolov K, Spasic P, Bojanic N: Evidence of a viral aetiology in endemic (Balkan) nephropathy. Lancet 1975;ii:1271-1273.
64. Uzelac-Keserovic B, Spasic P, Bojanic N, et al: Isolation of a corona virus from kidney biopsies of endemic Balkan nephropathy patients. Nephron 1999;81:141-145.
65. Riquelme C, Escors D, Ortego J, et al: Nature of the virus associated with endemic Balkan nephropathy. Emerg Infect Dis 2002;8:869-870.
66. Toncheva D, Galabov AS, Laich A, et al: Urinary neopterin concentrations in patients with Balkan endemic nephropathy. Kidney Int 2003;64:1817-1821.
67. Tourraine JL, Malik MC, Stefanovic V, et al: Lack of recurrence of endemic nephropathy over the first five years following renal transplantation. Abstr 8th Int Congr Nephrol, Athens, 1981, p 487.
68. Reginster F, Jadoul M, van Ypersele de Strihou C: Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant 1997;12:81-86.
69. Stefanovic V, Polenakovic M: Balkan nephropathy. Kidney disease beyond the Balkans? Am J Nephrol 1991;11:1-11.
70. Cosyns JP: Aristolochic acid and 'Chinese herbs nephropathy'. A review of the evidence to date. Drug Saf 2003;26:33-48.
71. Stefanovic V, Radenkovic S, Cukuranovic R, Kostic S: Balkan endemic nephropathy: avoidance of etiological factors arrests progression of kidney disease. Nephron 1999;83:85-86.